China: Exploring Applications For Chemical Patents And Experimental Data

Chemistry inventions in the majority of cases require experimental results for validation, only after which can they be confirmed. Here we will explore the importance of experimental data in applications for chemical patents.

Full disclosure

The third paragraph of article 26 of the Patent Law specifies that "the description shall provide a clear and complete description of the invention or utility model such that a person skilled in the art could realise the same". Pursuant to the Patent Examination Guidelines, the phrase "such that a person skilled in the art could realise the same" means that such a person skilled in the art could, based on the information contained in the description, realise the technical solution of the invention or utility model, resolve its technical issues and produce the anticipated technical effect.

A problem often seen in applications for chemical patents is a lack in the description of qualitative or quantitative experimental data for realising the purpose and/or achieving the anticipated effect. Consequently, a complete description of the invention is not established, resulting in insufficient disclosure.

The requirement of full disclosure can only be satisfied if the description contains experimental data on the effect of the specific compound, although there has been a trend in judicial cases in recent years of lowering the threshold on this requirement.

Cases that have drawn a great deal of attention include the Pfizer invalidation case (administrative judgment [2006] Gao Xing Zhong Zi No. 519 of the Beijing Higher People's Court) and the Eli Lilly review case (administrative judgment [2013] Gao Xing Zhong Zi No. 963 of the Beijing Higher People's Court).

The point in common in these two cases is the failure to expressly state in the description which specific compound the experimental data comes from.

Eli Lilly's patent application No. 200580005788.4 involves compounds of a general formula, with the description providing experimental data on "representative compounds" and "exemplified compounds". The review decision and judgment at first instance were overturned on appeal, finding that the compounds of the general formula in the patent application satisfied the basic requirements for full disclosure. However, it was also found that because there was no experimental data for specific example compounds, the application could not request protection for specific example compounds.

Claim support

The fourth paragraph of article 26 specifies that "the claims shall be based on the description and concisely delimit the scope of patent protection that is claimed". Pursuant to the Patent Examination Guidelines, the phrase "the claims shall be based on the description" means that the claims should be supported by the description.

Usually the claims are reasonable summaries of the specific examples in the description. If the technical solution summarised by a claim includes a solution that is not capable of implementation, or a solution inferred by the applicant, and its effect cannot be determined or evaluated in advance, then such a claim will be found to be unsupported by the description.

The Takeda Pharmaceutical Company invalidation case (administrative ruling [2012] Zhi Xing Zi No. 4 of the Supreme People's Court) involved invention patent No. 93100008.4. The Supreme People's Court found that the description for the patent did not provide sufficient experimental data to show that, in addition to PEG 6000, "oxyalkylene polymers with a melting point range of 20-90°C" or "PEG with a molecular weight of 1,000-10,000" can likewise realise the objectives of the invention, resulting in the claims being unsupported by the description.

Determining inventiveness

Pursuant to the third paragraph of article 22 of the Patent Law, "the term 'inventive' means that, in comparison with prior art, the invention has prominent substantive features and represents distinctive progress, or that the utility model has substantive features and represents progress". In patent practice, inventiveness requires the invention to be non-obvious and with a beneficial effect, or merely to produce an unexpected technical effect. Such effect needs to be recorded in the description for it to serve as a basis for determining inventiveness. Supplementary experimental data that substantiate an unexpected technical effect can be used to argue for inventiveness, provided that the technical effect is expressly recorded in the description.

The Xiangbei Welman invalidation case ([2011] Xing Ti Zi No. 9 of the Supreme People's Cour t) involved invention patent No. ZL97108942.6, a patent that requests protection for a compound preparation. The patent holder claimed that the compound preparation was safe, effective and stable, but failed to record this in the description. The Supreme People's Court found that, in general, technical solutions and technical effects that an applicant fails to disclose in the description may not serve as the basis for determining whether an application satisfies the statutory criteria for a patent to be granted, otherwise this would clash with the first-to-file principle in patent regulations and run counter to the essential attribute of a patent, i.e. exchanging disclosure for protection.

Mutual connection

A lack of the necessary experimental data will on the one hand result in insufficient disclosure of the technical solution in the description for which the claims request protection, and on the other hand the claim will be unsupported by the description. If the use and/or technical effect can be anticipated from prior art, the invention will generally lack inventiveness, despite the requirement of full disclosure being satisfied.

In patent practice, with respect to the issues of full disclosure and support, supplementary experimental data will generally not be taken into consideration. However, one should be mindful that the most recent criteria for the examination of full disclosure have changed, in that supplementary experimental data provided as evidence in support of the facts are acceptable. In the chemistry field, experimental data are of utmost importance for the determination of full disclosure, support and inventiveness. It can be anticipated that, with the lowering of the threshold for the criteria for the examination of full disclosure, the threshold for the criteria for the examinations of support and inventiveness will be correspondingly raised, thereby achieving a new balance.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions